MONDAY, April 12, 2021 (HealthDay News) — Most people are familiar with common sun-protection advice, from wearing and reapplying sunscreen to putting on a hat. But a new Canadian study finds that for people who take certain blood pressure medications, that advice becomes even more critical because those drugs canContinue Reading

MONDAY, April 12, 2021 (HealthDay News) — People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron’s antibody cocktail, a new study shows. The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktailContinue Reading

MONDAY, April 12, 2021 (HealthDay News) — Once you’ve landed that coveted coronavirus vaccine appointment, you’ll likely have to fill out a form on your medical history and whether you’re allergic to any of the vaccine’s ingredients. But there could be another question waiting for you: Have you ever hadContinue Reading

MONDAY, April 12, 2021 (HealthDay News) — Older adults in long-term care develop detectible antibodies after COVID-19 vaccination, which may mean it’s safe to reopen these facilities, according to a new study. But because it’s unclear how long the antibodies last, researchers from University of Pittsburgh Medical Center (UPMC) sayContinue Reading

FRIDAY, April 9, 2021 (HealthDay News) — Doctors might have figured out why AstraZeneca’s COVID-19 vaccine may cause life-threatening blood clots in very rare cases. The discovery, made in a pair of reports published online Friday in the New England Journal of Medicine, could be key to the global rolloutContinue Reading

THURSDAY, April 8, 2021 (HealthDay News) — A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines. “The public understandably has been concernedContinue Reading

THURSDAY, April 8, 2021 (HealthDay News) — Two COVID-19 vaccines appear to work well against a rapidly spreading coronavirus variant that arose in California, but less effective against a variant that first emerged in South Africa, researchers report. “The good news is the California variant does not appear to beContinue Reading